Myocardial T1 mapping.
暂无分享,去创建一个
James C Moon | Chiara Bucciarelli-Ducci | Viviana Maestrini | Stefania Rosmini | Thomas A Treibel | Heerajnarain Bulluck | Charlotte Manisty | J. Moon | C. Manisty | S. Castelletti | S. Rosmini | T. Treibel | H. Bulluck | V. Maestrini | C. Bucciarelli-Ducci | A. Abdel‐Gadir | Silvia Castelletti | Amna Abdel-Gadir
[1] S. Heymans,et al. Replacement and reactive myocardial fibrosis in idiopathic dilated cardiomyopathy: comparison of magnetic resonance imaging with right ventricular biopsy , 2010, European journal of heart failure.
[2] M. Beer,et al. Impact of Myocardial Fibrosis in Patients With Symptomatic Severe Aortic Stenosis , 2009, Circulation.
[3] David M Higgins,et al. Modified Look‐Locker inversion recovery (MOLLI) for high‐resolution T1 mapping of the heart , 2004, Magnetic resonance in medicine.
[4] L. Ling,et al. Diffuse Ventricular Fibrosis Is a Late Outcome of Tachycardia-Mediated Cardiomyopathy After Successful Ablation , 2013, Circulation. Arrhythmia and electrophysiology.
[5] Dudley J Pennell,et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. , 2006, Journal of the American College of Cardiology.
[6] Dudley J. Pennell,et al. Cardiovascular Magnetic Resonance , 2010, Circulation.
[7] Richard B. Thompson,et al. Accuracy, precision, and reproducibility of four T1 mapping sequences: a head-to-head comparison of MOLLI, ShMOLLI, SASHA, and SAPPHIRE. , 2014, Radiology.
[8] W. Kim,et al. Mass Reduction and Functional Improvement of the Left Ventricle after Aortic Valve Replacement for Degenerative Aortic Stenosis , 2011, The Korean journal of thoracic and cardiovascular surgery.
[9] M. Hayward,et al. Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis: Preliminary Validation in Humans , 2010, Circulation.
[10] S. Neubauer,et al. Evaluation and management of the cardiac amyloidosis. , 2007, Journal of the American College of Cardiology.
[11] G. Maurer,et al. Magnetic Resonance Postcontrast T 1 Time Is Associated With Outcome in Patients With Heart Failure and Preserved Ejection Fraction , 2022 .
[12] P. Kellman,et al. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. , 2012, European heart journal.
[13] Andrew S Flett,et al. Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR , 2012, Journal of Cardiovascular Magnetic Resonance.
[14] M. Friedrich,et al. Cardiac Magnetic Resonance Assessment of Myocarditis , 2013, Circulation. Cardiovascular imaging.
[15] J. Townend,et al. Defining the natural history of uremic cardiomyopathy in chronic kidney disease: the role of cardiovascular magnetic resonance. , 2014, JACC. Cardiovascular imaging.
[16] Reza Razavi,et al. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. , 2013, JACC. Cardiovascular imaging.
[17] Steffen Ringgaard,et al. Assessment of intramyocardial hemorrhage by T1-weighted cardiovascular magnetic resonance in reperfused acute myocardial infarction , 2012, Journal of Cardiovascular Magnetic Resonance.
[18] C. Kramer,et al. Cardiovascular Magnetic Resonance Applications in Daily Practice , 2011 .
[19] C. Wanner,et al. Fabry disease and the heart. , 2015, Best practice & research. Clinical endocrinology & metabolism.
[20] L. Ling,et al. Diffuse ventricular fibrosis in atrial fibrillation: noninvasive evaluation and relationships with aging and systolic dysfunction. , 2012, Journal of the American College of Cardiology.
[21] A. Flett,et al. Quantification of Myocardial Extracellular Volume Fraction in Systemic AL Amyloidosis: An Equilibrium Contrast Cardiovascular Magnetic Resonance Study , 2013, Circulation. Cardiovascular imaging.
[22] P. Matthews,et al. Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis – a clinical study using myocardial T1-mapping and extracellular volume quantification , 2014, Journal of Cardiovascular Magnetic Resonance.
[23] James O. Mudd,et al. T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy. , 2012, Radiology.
[24] Andrew S Flett,et al. Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease , 2012, Heart.
[25] M. Robson,et al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. , 2013, JACC. Cardiovascular imaging.
[26] S. K. White,et al. Identification and Assessment of Anderson-Fabry Disease by Cardiovascular Magnetic Resonance Noncontrast Myocardial T1 Mapping , 2013, Circulation. Cardiovascular imaging.
[27] P. Weale,et al. Optimization and comparison of myocardial T1 techniques at 3T in patients with aortic stenosis , 2013, European heart journal cardiovascular Imaging.
[28] Pierre Croisille,et al. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. , 2011, Journal of the American College of Cardiology.
[29] Matthew W. Darlison,et al. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[30] S. Neubauer,et al. The Prognostic Value of Late Gadolinium Enhancement CMR in Nonischemic Cardiomyopathies , 2012, Current Cardiology Reports.
[31] B. Prendergast,et al. Rationale and design of the PRognostic Importance of MIcrovascular Dysfunction in asymptomatic patients with Aortic Stenosis (PRIMID-AS): a multicentre observational study with blinded investigations , 2013, BMJ Open.
[32] G. Maurer,et al. Cardiac Magnetic Resonance Postcontrast T1 Time Is Associated With Outcome in Patients With Heart Failure and Preserved Ejection Fraction , 2013, Circulation. Cardiovascular imaging.
[33] D. Kaye,et al. Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis. , 2015, European heart journal cardiovascular Imaging.
[34] S. Nattel,et al. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. , 2008, Journal of the American College of Cardiology.
[35] C. Jellis,et al. Myocardial T1 mapping: modalities and clinical applications. , 2013, Cardiovascular diagnosis and therapy.
[36] Michael Jerosch-Herold,et al. Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. , 2008, American journal of physiology. Heart and circulatory physiology.
[37] M. Robson,et al. T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique. , 2013, JACC. Cardiovascular imaging.
[38] R. Fimmers,et al. Acute myocarditis: multiparametric cardiac MR imaging. , 2014, Radiology.
[39] Sandeep N. Gupta,et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. , 2008, Journal of the American College of Cardiology.
[40] E. Nagel,et al. Native Myocardial T1 Mapping by Cardiovascular Magnetic Resonance Imaging in Subclinical Cardiomyopathy in Patients With Systemic Lupus Erythematosus , 2013, Circulation. Cardiovascular imaging.
[41] Peter Kellman,et al. Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method , 2012, Journal of Cardiovascular Magnetic Resonance.
[42] U. Sechtem,et al. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging. , 2014, European heart journal cardiovascular Imaging.
[43] Mehmet Akçakaya,et al. Combined saturation/inversion recovery sequences for improved evaluation of scar and diffuse fibrosis in patients with arrhythmia or heart rate variability , 2014, Magnetic resonance in medicine.
[44] M. Robson,et al. Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents , 2014, Journal of Cardiovascular Magnetic Resonance.
[45] S. Plein,et al. Myocardial T1 mapping: Application to patients with acute and chronic myocardial infarction , 2007, Magnetic resonance in medicine.
[46] Stefan Neubauer,et al. Dynamic Changes of Edema and Late Gadolinium Enhancement After Acute Myocardial Infarction and Their Relationship to Functional Recovery and Salvage Index , 2011, Circulation. Cardiovascular imaging.
[47] Andrew J Taylor,et al. Magnetic resonance post-contrast T1 mapping in the human atrium: validation and impact on clinical outcome after catheter ablation for atrial fibrillation. , 2014, Heart rhythm.
[48] O. Simonetti,et al. Direct T2 quantification of myocardial edema in acute ischemic injury. , 2011, JACC. Cardiovascular imaging.
[49] Stefan L. Zimmerman,et al. Cardiac magnetic resonance T1 mapping of left atrial myocardium. , 2013, Heart rhythm.
[50] S. K. White,et al. Native T1 mapping in transthyretin amyloidosis. , 2014, JACC. Cardiovascular imaging.
[51] Richard B. Thompson,et al. T1 Mapping With Cardiovascular MRI Is Highly Sensitive for Fabry Disease Independent of Hypertrophy and Sex , 2013, Circulation. Cardiovascular imaging.
[52] P. Elliott,et al. Anderson-Fabry disease and the heart. , 2010, Progress in cardiovascular diseases.
[53] E. Nagel,et al. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[54] A. Dart,et al. Acute left ventricular remodeling following myocardial infarction: coupling of regional healing with remote extracellular matrix expansion. , 2012, JACC. Cardiovascular imaging.
[55] Sung Ho Hwang,et al. Diagnosis of Acute Global Myocarditis Using Cardiac MRI with Quantitative T1 and T2 Mapping: Case Report and Literature Review , 2013, Korean journal of radiology.
[56] A. Taylor,et al. Diffuse myocardial fibrosis in severe aortic stenosis: an equilibrium contrast cardiovascular magnetic resonance study. , 2012, European heart journal cardiovascular Imaging.
[57] P. Kellman,et al. T1-mapping in the heart: accuracy and precision , 2014, Journal of Cardiovascular Magnetic Resonance.
[58] D. Look,et al. Time Saving in Measurement of NMR and EPR Relaxation Times , 1970 .
[59] Yong-Jin Kim,et al. Assessment of diffuse myocardial fibrosis by using MR imaging in asymptomatic patients with aortic stenosis. , 2015, Radiology.
[60] L. Kuller,et al. Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. , 2014, European heart journal.
[61] Jennifer Taylor,et al. ESC/EACTS Guidelines on the management of valvular heart disease. , 2012, European heart journal.
[62] Andrew S Flett,et al. Human non-contrast T1 values and correlation with histology in diffuse fibrosis , 2013, Heart.
[63] S. K. White,et al. Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance , 2014, Journal of Cardiovascular Magnetic Resonance.
[64] Andreas Greiser,et al. Optimization and validation of a fully‐integrated pulse sequence for modified look‐locker inversion‐recovery (MOLLI) T1 mapping of the heart , 2007, Journal of magnetic resonance imaging : JMRI.
[65] Stephane Heymans,et al. Myocardial Extracellular Matrix: An Ever-Changing and Diverse Entity , 2014, Circulation research.
[66] G. Faggian,et al. Prognostic value of myocardial fibrosis in patients with severe aortic valve stenosis. , 2012, The Journal of thoracic and cardiovascular surgery.
[67] P. Croisille,et al. Quantification of myocardial extracellular volume fraction with cardiac MR imaging for early detection of left ventricle involvement in systemic sclerosis. , 2014, Radiology.
[68] S. K. White,et al. Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI , 2013, Journal of Cardiovascular Magnetic Resonance.
[69] J. Moon,et al. Review of T1 Mapping Methods: Comparative Effectiveness Including Reproducibility Issues , 2014, Current Cardiovascular Imaging Reports.
[70] S. K. White,et al. Noncontrast myocardial T1 mapping using cardiovascular magnetic resonance for iron overload , 2015, Journal of magnetic resonance imaging : JMRI.
[71] C. Jellis,et al. Myocardial T1 mapping: modalities and clinical applications. , 2013, Cardiovascular diagnosis and therapy.
[72] L. Brunereau,et al. Cardiac magnetic resonance T1 mapping pre and post contrast in heart transplant patients with clinical antibody-mediated rejection: a preliminary experience , 2014, Journal of Cardiovascular Magnetic Resonance.
[73] Stefan Neubauer,et al. T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. , 2013, JACC. Cardiovascular imaging.
[74] Helmut Baumgartner,et al. Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology , 2007 .
[75] J. Moon,et al. Cardiac amyloid burden assessment by T1 mapping predicts survival in patients with systemic AL amyloidosis - a 2 year follow-up study , 2014, Journal of Cardiovascular Magnetic Resonance.
[76] R. Mitchell,et al. Quantification of Cardiomyocyte Hypertrophy by Cardiac Magnetic Resonance: Implications for Early Cardiac Remodeling , 2013, Circulation.
[77] W. Tseng,et al. CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF. , 2014, JACC. Cardiovascular imaging.
[78] E. Cassinerio,et al. An update on iron chelation therapy. , 2012, Blood transfusion = Trasfusione del sangue.
[79] M. Robson,et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement , 2013, Journal of Cardiovascular Magnetic Resonance.
[80] Helen J. Lachmann,et al. T1 mapping and survival in systemic light-chain amyloidosis , 2015, European heart journal.
[81] Stefan Neubauer,et al. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold , 2010, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[82] Richard B Thompson,et al. Saturation recovery single‐shot acquisition (SASHA) for myocardial T1 mapping , 2014, Magnetic resonance in medicine.
[83] Stefan Neubauer,et al. Myocardial Tissue Characterization Using Magnetic Resonance Noncontrast T1 Mapping in Hypertrophic and Dilated Cardiomyopathy , 2012, Circulation. Cardiovascular imaging.
[84] M. Robson,et al. Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance , 2012, Journal of Cardiovascular Magnetic Resonance.